Gemini Polskasp. z o.o.

Activities of holding companies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-01-12
Share capital
119 153 550,00 PLN
Activity description

Gemini Polska operates the Gemini.pl health platform and online drugstore with nearly 27,000 products available immediately. Its range includes medicines, medical devices, cosmetics, dietary supplements and everyday personal-care products, with shopping available 24/7.

Registered address
Aleja Grunwaldzka 411, 80-309 Gdańsk, Poland
Website
gemini.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-81912-63143-WGDTB-31

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 102.14mMedianUSD 45.21kAverageUSD 4.41m
Net profit
This companyUSD 26.04mMedianUSD 15.14AverageUSD 698.62k
Operating costs
This companyUSD 44.78mMedianUSD 11.27kAverageUSD 3.07m
Assets
This companyUSD 222.55mMedianUSD 883.18kAverageUSD 22.38m

Bank accounts

Registered as a VAT taxpayer on 2016-01-18. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Nov 8, 2017Merger registered

Public aid

Grant datePurposeGross amountGranting body
Jul 30, 2021
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$9,886Prezydent Miasta Gdańsk
May 24, 2019
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,500PREZYDENT MIASTA GDAŃSK
Mar 7, 2018
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,214PREZYDENT MIASTA GDAŃSK

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Grzegorz Bolesław Postolski — Management Board Member
Grzegorz Sadowski — Management Board Member
Roman Piotr Pałac — President of the Management Board
Sebastian Trzmiel — Management Board Member

Manner of representation

In the case of a one-person management board, the sole member of the management board is authorised to independently make declarations of will on behalf of the company and to represent it. In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to make declarations on behalf of the company and represent it.

Supervisory board

Tony Leon Housh — Supervisory Board Member
Michał Tomasz Krupiński — Supervisory Board Member
Paweł Moskwa — Supervisory Board Member
Siegfried Seewald — Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Value Pharmacy B.v.
2,383,071$32,186,264.18100%

Beneficial owners

PersonRights
Roman Piotr Pałac (46)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Grzegorz Bolesław Postolski (45)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Grzegorz Sadowski (51)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Sebastian Trzmiel (45)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Subsidiaries

NameShare valueStake
Vitasp. z o.o.
67,531.06 USD100%
Eurekasp. z o.o.
13,506.21 USD100%
4,240,950.84 USD100%

Capital group

Competitors

NameRevenueWebsite
PelionS.A.$99,756,667.36pelion.eu

Change history

DateEvent
2023-06-07Address change (Al. Grunwaldzka 411, 80-309, Gdańsk → Aleja Grunwaldzka 411, 80-309, Gdańsk)
2019-08-27Share capital change (35,392,350.00 PLN → 119,153,550.00 PLN)
2017-10-31Address change (Al. Aleje Jerozolimskie 56c, 00-803, Warszawa → Al. Grunwaldzka 411, 80-309, Gdańsk)
2017-10-31Name change (Northern Pharmacies → Gemini Polska)
2017-08-16Share capital change (1,133,150.00 PLN → 35,392,350.00 PLN)

FAQ

Last updated: 2026-07-04